Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 5, 2009, Pages 309-312

  Brown, Kathy ^a   Subramony, Charu ^b   May, Warren ^c   Megason, Gail ^c   Liu, Hua ^a   Bishop, Phyllis ^a   Walker, Teresa ^c   Nowicki, Michael J ^a,d  

^a Department of Pediatric

^b Blair E Batson Hospital for Children   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Chelation therapy; Hepatic injury; Hepatic iron content; Iron overload

Indexed keywords

FERRITIN; IRON; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; BLOOD VOLUME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; GROUPS BY AGE; HEPATITIS; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IRON BLOOD LEVEL; IRON CHELATION; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; LIVER WEIGHT; MALE; MEDICAL RECORD; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; TREATMENT DURATION; BIOPSY; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ADOLESCENT; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HEPATITIS; HUMANS; IRON; IRON OVERLOAD; LIVER; LIVER CIRRHOSIS; MALE;

EID: 66149149084     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181a1c143     Document Type: Article

References (16)

1. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1999;339:5-11.
2. Adams RJ, Brambilla D. Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP2) Trial Investigator. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769-2778.
3. Barton JC, Edwards CQ, Bertoli LF, et al. Iron overload in African Americans. Am J Med. 1995;99:616-623.
4. Teixeira A, Viana M, Roquete M, et al. Sickle cell disease: a clinical and histopathologic study of the liver in living children. J Pediatr Hematol Oncol. 2002;24:125-129.
5. Olivieri NF. Progression of iron overload in sickle cell disease. Semin Hematol. 2001;38(1 suppl 1):57-62.
6. Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000;96:76-79.
7. Cohen MB, A-Kader HH, Lambers D, et al. Complications of percutaneous liver biopsy in children. Gastroenterology. 1992; 102:629-632.
8. Gonzalez-Vallina R, Alsono EM, Rand E, et al. Outpatient percutaneous liver biopsy in children. J Pediatr Gastroenterol Nutr. 1993;17:370-375.
9. Zakaria N, Knisely A, Portmann B, et al. Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood. 2003;101:101-103.
10. Gungor T, Rohrbach E, Solem E, et al. Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis. Arch Dis Child. 1996;74:323-327.
11. Brittenham GH, Farrell DE, Harris JW, et al. Magneticsusceptibility measurement of human iron stores. N Engl J Med. 1982;307:1671-1675.
12. Kaltwasser JP, Gottschalk R, Schalk KP, et al. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol. 1990;74:360-363.
13. Chan YL, Li CK, Lam CW, et al. Liver iron estimation in beta-thalassaemia: comparison of MRI biochemical assay and histological grading. Clin Radiol. 2001;56:911-916.
14. Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004; 363:357-362.
15. Angelucci E, Giovagnoni A, Valeri G, et al. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood. 1997;90:4736-4742.
16. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739-761.